Addressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
Recent tumor sequencing data suggest an urgent need to develop a methodology to directly address intratumoral heterogeneity in the design of anticancer treatment regimens. We use RNA interference to model heterogeneous tumors, and demonstrate successful validation of computational predictions for ho...
Main Authors: | Zhao, Boyang (Contributor), Pritchard, Justin R. (Contributor), Hemann, Michael (Contributor), Lauffenburger, Douglas A (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Computational and Systems Biology Program (Contributor), Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Lauffenburger, Douglas A. (Contributor) |
Format: | Article |
Language: | English |
Published: |
American Association for Cancer Research,
2014-09-04T19:37:06Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Intratumor heterogeneity alters most effective drugs in designed combinations
by: Zhao, Boyang, et al.
Published: (2015) -
Modeling Tumor Clonal Evolution for Drug Combinations Design
by: Zhao, Boyang, et al.
Published: (2018) -
Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations
by: Sun, Daphne S., et al.
Published: (2017) -
Understanding resistance to combination chemotherapy
by: Pritchard, Justin R., et al.
Published: (2014) -
Exploiting Temporal Collateral Sensitivity in Tumor Clonal Evolution
by: Zhao, Boyang, et al.
Published: (2017)